Reported sales and earnings from the publicly traded cardiovascular device companies show strong performance across the sector, spurred by new approvals and clinical trials, in the quarter that ended Sept. 30. Here's a recap of results from the cardio device companies that have reported so far, including Abbott, Abiomed, and Reva.
• Source: shutterstock.com
[Editor's note: Look out for upcoming recaps of earnings reports in the IVD and orthopedics sectors.]
